Possible role of edotecarin, a novel topoisomerase I inhibitor, in theraphy-related myelodysplastic syndrome Journal Article


Authors: Carvajal, R. D.; Ilson, D.; Noy, A.
Article Title: Possible role of edotecarin, a novel topoisomerase I inhibitor, in theraphy-related myelodysplastic syndrome
Keywords: adult; acute granulocytic leukemia; clinical feature; histopathology; neutropenia; case report; squamous cell carcinoma; carcinoma, squamous cell; cisplatin; fluorouracil; drug dose reduction; antineoplastic agents; cancer staging; positron emission tomography; follow up; antineoplastic agent; letter; computer assisted tomography; multiple cycle treatment; thrombocytopenia; drug antagonism; myelodysplastic syndrome; fluorescence in situ hybridization; chemically induced disorder; platinum derivative; indoles; mitomycin; indole derivative; patient attitude; lymph node biopsy; lymphadenopathy; myelodysplastic syndromes; cytodiagnosis; blood smear; dna topoisomerase; dna topoisomerases, type i; carbazoles; anus neoplasms; anus tumor; anus carcinoma; carbazole derivative; edotecarin; erythrocyte concentrate
Journal Title: Leukemia and Lymphoma
Volume: 48
Issue: 1
ISSN: 1042-8194
Publisher: Taylor & Francis Group  
Date Published: 2007-01-01
Start Page: 192
End Page: 194
Language: English
DOI: 10.1080/10428190600968350
PUBMED: 17325867
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 17 November 2011" - "CODEN: LELYE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ariela Noy
    351 Noy
  2. Richard D Carvajal
    148 Carvajal
  3. David H Ilson
    433 Ilson